Herpes Labialis: A New Possibility for Topical Treatment with Well-Elucidated Drugs-Reference-Cited by-同舟云学术

Herpes Labialis: A New Possibility for Topical Treatment with Well-Elucidated Drugs

Published:2021-10 Issue:10 Volume:110 Page:3450-3456
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Silva-Alvarez Amanda F.,de Carvalho Ana Clara Wada,Benassi-Zanqueta Érica,Oliveira Thalita Z.,Fonseca Dyenefer P.,Ferreira Maíra P.,Vicentini Fabiana T.M.C.,Ueda-Nakamura Tania,Pedrazzi Vinicius,de Freitas Osvaldo

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012;Looker;PLoS One,2015

2. Infection and transport of herpes simplex virus type 1 in neurons: role of the cytoskeleton;Miranda-Saksena;Viruses,2018

3. Local anesthetic improves individuals affected with herpes simplex type 1 labialis;Bastos;J Med Virol,2020

4. Herpes simplex virus resistance to antivirals;Morfin;J Clin Virol,2002

5. Acyclovir resistance in herpes simplex virus type I encephalitis: a case report;Bergmann;J Neurovirol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioadhesive gel containing 5 % acyclovir for the treatment of herpes labialis: Preclinical development;Journal of Drug Delivery Science and Technology;2024-10

2. Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion;International Journal of Pharmaceutics;2023-08

3. L‐lysine: Its antagonism with L‐arginine in controlling viral infection. Narrative literature review;British Journal of Clinical Pharmacology;2022-07-05